---
layout: post
title: TXNDC9
date: 2025-01-17 16:55 CST
description: TXNDC9 description
tags: [cooccuring-genes]
categories: unknown-mechanism
pretty_table: true
citation: true
related_posts: true
---



| [NCBI ID](https://www.ncbi.nlm.nih.gov/gene/10190) | NCBI symbol | ENSEMBL ID | Chromosome location |
| :-------- | :------- | :-------- | :------- |
| 10190  | TXNDC9 | ENSG00000115514 | 2q11.2 |



The gene is involved in [microtubule cytoskeleton organization](https://amigo.geneontology.org/amigo/term/GO:0000226) and [biological_process](https://amigo.geneontology.org/amigo/term/GO:0008150). It enables [protein binding](https://amigo.geneontology.org/amigo/term/GO:0005515) and [cadherin binding](https://amigo.geneontology.org/amigo/term/GO:0045296). The gene is located in the [nucleus](https://amigo.geneontology.org/amigo/term/GO:0005634), [cytoplasm](https://amigo.geneontology.org/amigo/term/GO:0005737), [centrosome](https://amigo.geneontology.org/amigo/term/GO:0005813), [cytosol](https://amigo.geneontology.org/amigo/term/GO:0005829), and [midbody](https://amigo.geneontology.org/amigo/term/GO:0030496).


The gene length for 10190 is 10,360 base pairs (26.52 percentile of all genes), with a mature length of 2,119 base pairs and a primary transcript length of 10,360 base pairs.


The gene TXNDC9 (NCBI ID: 10190) has been mentioned in [9 publications](https://pubmed.ncbi.nlm.nih.gov/?term=%22TXNDC9%22) according to [Pubtator](https://academic.oup.com/nar/article/47/W1/W587/5494727), with the earliest publication in 2012 and the middle 50% of publications occurring between 2017 and 2021. Note that the publication count in the hyperlink may be different since the count is from Pubtator.


The top 5 publications mentioning TXNDC9 include studies that highlight its role in various cancer types and its potential as a biomarker. The [Relative Citation Ratio (RCR)](https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002541) measures the scientific influence of each paper by field- and time-adjusting the citations it has received, benchmarking to the median for NIH publications, which is set at 1.0. Notable publications include "[TXNDC9 regulates oxidative stress-induced androgen receptor signaling to promote prostate cancer progression.](https://pubmed.ncbi.nlm.nih.gov/31477836)" (2020) (relative citation ratio: 1.61), "[TXNDC9 expression in colorectal cancer cells and its influence on colorectal cancer prognosis.](https://pubmed.ncbi.nlm.nih.gov/23210642)" (2012) (relative citation ratio: 0.38), and "[Knockdown of TXNDC9 induces apoptosis and autophagy in glioma and mediates cell differentiation by p53 activation.](https://pubmed.ncbi.nlm.nih.gov/32897242)" (2020) (relative citation ratio: 0.33). The citation counts are sourced from [iCite](https://icite.od.nih.gov).


[TXNDC9](https://www.proteinatlas.org/ENSG00000115514-TXNDC9) is a gene with evidence at the protein level, detected in all RNA tissue distributions. It is primarily located in the cytosol and is associated with various expression clusters, including Cluster 42 for blood expression (Non-specific - Vesicular transport), Cluster 11 for tissue expression (Liver - Plasma proteins), Cluster 27 for brain expression (Non-specific - Mixed function), Cluster 26 for cell line expression (Non-specific - Mitochondria & RNA binding), and Cluster 15 for single cell expression (Non-specific - Mixed function).


The top transcription factors (TFs) identified from the GTRD database, based on the number of CHIP-seq experiments, include [INTS11](https://www.ncbi.nlm.nih.gov/gene/54973), [EP300](https://www.ncbi.nlm.nih.gov/gene/2033), [RBFOX2](https://www.ncbi.nlm.nih.gov/gene/23543), [PGR](https://www.ncbi.nlm.nih.gov/gene/5241), and [PPARG](https://www.ncbi.nlm.nih.gov/gene/5468), each with 5 experiments demonstrating their regulatory roles.



The GWAS data indicates associations with various mental health conditions, including cognitive disorder, mood disorder, endogenous depression, major depressive disorder, and mental depression.



The gene is expressed in various immune and blood cell types, including CD34+ cells, CD56+ NK cells, and whole blood. Additionally, it is found in CD105+ endothelial cells, CD71+ early erythroid cells, smooth muscle, and bronchial epithelial cells. The gene is also expressed in skin tissue.




The analyzed protein sequence has a GRAVY value of -0.815 (10.97th percentile), indicating a hydrophilic nature. At pH 7.0, the protein carries a charge of -6.86 (28.82nd percentile). The median structural flexibility is 1.012 (85.4th percentile), with a predicted secondary structure composition of 38.5% helix (90.09th percentile), 35.0% sheet (58.84th percentile), and 23.9% turn (14.41st percentile). The instability index is 31.78 (5.63rd percentile), and the isoelectric point is 5.61 (20.76th percentile). The protein is 226 amino acids long (18.41st percentile) with a molecular weight of 26533.72 Da (20.06th percentile). For more details on the sequence analysis, refer to the [BioPython documentation](https://biopython.org/docs/1.75/api/Bio.SeqUtils.ProtParam.html).





| Checks    | Answer |
| :-------- | :------- |
| Sentiment  | neutral   |
| Ethical concerns | no     |
| Coherence    | no    |